V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20176945 | 20066129 | 1.65 | 57.8 | Adjuvant (A) | 2019-11-02 | 2019-11-22 | Fluorouracil + Folinic Acid Weekly | 02 | N | FLUOROURACIL | 101300170 |
| 20176947 | 20066130 | 1.75 | 73.4 | Neo-adjuvant (N) | 2020-03-12 | 2020-03-26 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101307062 |
| 20176953 | 20066131 | 1.7 | 91.8 | Palliative (P) | 2016-05-03 | 2016-05-28 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100572064 |
| 20176954 | 20066132 | 1.62 | 70 | Palliative (P) | 2019-01-20 | 2019-01-24 | ECX | 02 | null | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101573768 |
| 20176963 | 20066133 | 1.82 | 44.9 | Palliative (P) | 2019-11-08 | 2019-11-14 | ECX | 02 | null | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100817911 |
| 20176974 | 20066134 | 1.76 | 61.2 | Palliative (P) | 2018-09-26 | 2018-11-12 | ECX | 02 | Y | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100522350 |
| 20176976 | 20066135 | 1.75 | 71.9 | Palliative (P) | 2017-06-10 | 2017-06-10 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100481995 |
| 20176978 | 20066136 | 1.56 | 74.9 | Palliative (P) | 2019-02-15 | 2019-03-05 | Fluorouracil + Folinic Acid Weekly | 02 | N | FLUOROURACIL | 101733509 |
| 20176979 | 20066137 | 1.56 | 58.6 | Adjuvant (A) | null | 2019-05-18 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100305978 |
| 20176983 | 20066138 | 1.61 | 72.7 | Neo-adjuvant (N) | 2016-12-02 | 2016-12-09 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100819004 |
| 20176984 | 20066139 | 1.63 | 63 | Adjuvant (A) | 2019-01-11 | 2019-01-12 | Fluorouracil + Folinic Acid Weekly | 02 | N | FLUOROURACIL | 101610241 |
| 20176986 | 20066140 | 1.83 | 92.9 | Neo-adjuvant (N) | 2018-01-24 | 2018-01-27 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101300245 |
| 20176990 | 20066141 | 1.58 | 50.4 | Neo-adjuvant (N) | 2018-07-11 | 2018-07-20 | ECX | 02 | null | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100742497 |
| 20177008 | 20066142 | null | null | Palliative (P) | 2017-09-06 | 2017-10-01 | Fluorouracil + Folinic Acid Weekly | N | null | FLUOROURACIL | 101352381 |
| 20177011 | 20066143 | null | 79 | Neo-adjuvant (N) | 2017-04-28 | 2017-04-28 | ECX | 02 | Y | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101355510 |
| 20177013 | 20066144 | 1.62 | 61.5 | Palliative (P) | 2016-02-24 | 2016-03-04 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101435131 |
| 20177017 | 20066145 | 1.82 | 49.4 | Neo-adjuvant (N) | 2017-12-23 | 2018-01-10 | Fluorouricil + Folonic Acid (MdG) | 02 | N | FLUOROURACIL | 100699427 |
| 20177021 | 20066146 | 1.77 | 91 | Curative (C) | 2018-10-02 | 2018-10-09 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101673972 |
| 20177025 | 20066147 | 1.66 | 74.2 | Neo-adjuvant (N) | 2019-01-25 | 2019-02-21 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101645212 |
| 20177027 | 20066148 | 1.56 | 66.2 | Adjuvant (A) | 2017-07-23 | 2017-08-08 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100177013 |
| 20177029 | 20066149 | 1.71 | 65.1 | Adjuvant (A) | 2019-05-18 | 2019-05-31 | Fluorouracil + Folinic Acid Weekly | N | N | FLUOROURACIL | 100043556 |
| 20177038 | 20066150 | 1.57 | 65 | Neo-adjuvant (N) | 2017-09-26 | 2017-10-07 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101815215 |
| 20177045 | 20066151 | null | null | Adjuvant (A) | 2016-07-07 | 2016-07-26 | Fluorouracil + Folinic Acid Weekly | 02 | Y | FLUOROURACIL | 100496097 |
| 20177050 | 20066152 | 1.57 | 76.25 | Adjuvant (A) | 2017-01-05 | 2017-01-12 | Fluorouracil + Folinic Acid Weekly | 02 | N | FLUOROURACIL | 100082167 |
| 20177054 | 20066153 | 1.86 | 47.1 | Palliative (P) | 2016-06-29 | 2016-07-03 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100312470 |
| 20177058 | 20066154 | 1.6 | 63.7 | Neo-adjuvant (N) | 2019-12-12 | 2019-12-29 | ECX | 02 | N | FLUOROURACIL | 100504647 |
| 20177065 | 20066155 | 1.74 | 54 | Adjuvant (A) | 2016-06-18 | 2016-06-26 | Fluorouricil + Folonic Acid (MdG) | 02 | N | FLUOROURACIL | 101684184 |
| 20177067 | 20066156 | 1.74 | 84 | null | 2016-02-21 | 2016-03-03 | ECX | 02 | N | FLUOROURACIL | 100630737 |
| 20177085 | 20066157 | 1.76 | 100.9 | Adjuvant (A) | 2018-01-05 | 2018-01-15 | Fluorouracil + Folinic Acid Weekly | 02 | N | FLUOROURACIL | 101078479 |
| 20177086 | 20066158 | 1.64 | 53 | null | 2019-05-16 | 2019-05-16 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100698331 |
| 20177088 | 20066159 | 1.78 | 78 | Adjuvant (A) | 2016-05-30 | 2016-06-18 | Fluorouracil + Folinic Acid Weekly | 02 | null | FLUOROURACIL | 101112913 |
| 20177094 | 20066160 | 1.86 | 90.4 | Palliative (P) | 2019-05-15 | 2019-05-15 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101562645 |
| 20177098 | 20066161 | 1.69 | 95 | Neo-adjuvant (N) | 2016-02-18 | 2016-03-03 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100628581 |
| 20177100 | 20066162 | 1.59 | 97 | Palliative (P) | 2017-03-24 | 2017-03-29 | Fluorouracil + Folinic Acid Weekly | 02 | N | FLUOROURACIL | 101869279 |
| 20177103 | 20066163 | 1.8 | 95.9 | Neo-adjuvant (N) | 2019-04-07 | 2019-04-07 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101546321 |
| 20177105 | 20066164 | 1.74 | 82.9 | Neo-adjuvant (N) | 2017-05-20 | 2017-05-28 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101468262 |
| 20177107 | 20066165 | 1.69 | 70 | Adjuvant (A) | 2018-01-05 | 2018-01-06 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100191574 |
| 20177110 | 20066166 | 1.56 | 56.8 | Neo-adjuvant (N) | 2017-07-03 | 2017-07-03 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101274310 |
| 20177111 | 20066167 | 1.68 | 133 | Neo-adjuvant (N) | 2019-10-01 | 2019-10-22 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100120409 |
| 20177112 | 20066168 | 1.7 | 79.8 | Adjuvant (A) | 2018-12-07 | 2018-12-14 | Fluorouracil + Folinic Acid Weekly | 02 | N | FLUOROURACIL | 100649788 |
| 20177114 | 20066169 | 1.72 | 103 | Palliative (P) | 2016-06-07 | 2016-06-15 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100616444 |
| 20177127 | 20066170 | 1.85 | 75 | Neo-adjuvant (N) | 2016-10-11 | 2016-10-24 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100173632 |
| 20177141 | 20066171 | 1.7 | 65.8 | Adjuvant (A) | 2018-07-29 | 2018-08-03 | Fluorouracil + Folinic Acid Weekly | 02 | N | FLUOROURACIL | 100403944 |
| 20177143 | 20066172 | 1.85 | 85.2 | Palliative (P) | 2017-01-17 | 2017-01-17 | Fluorouracil + Folinic Acid Weekly | 2 | N | FLUOROURACIL | 101145148 |
| 20177149 | 20066173 | 1.7 | 71.7 | Adjuvant (A) | 2019-09-19 | 2019-09-25 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100575838 |
| 20177151 | 20066174 | 1.77 | 58.2 | Neo-adjuvant (N) | 2016-02-08 | 2016-02-21 | FLUOROURACIL | 02 | N | FLUOROURACIL | 101107904 |
| 20177153 | 20066175 | null | 63.3 | Neo-adjuvant (N) | 2017-03-23 | 2017-03-30 | ECX | 02 | null | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101040699 |
| 20177154 | 20066176 | null | null | null | 2018-08-13 | 2018-08-22 | Fluorouricil + Folonic Acid (MdG) | 02 | N | FLUOROURACIL | 100394366 |
| 20177156 | 20066177 | 1.61 | 102.7 | Neo-adjuvant (N) | 2016-11-29 | 2016-12-01 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100455870 |
| 20177163 | 20066178 | 1.56 | 75.9 | Palliative (P) | 2017-05-19 | 2017-05-28 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100838028 |